Open Access Green as soon as Postprint is submitted to ZB.
Flavonoids and cinnamic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Mol. Cell. Endocrinol. 301, 229-234 (2009)
17beta-Hydroxysteroid dehydrogenase (17beta-HSD) type 1 converts estrone to estradiol, a potent ligand for estrogen receptors. It represents an important target for the development of drugs for treatment of estrogen-dependent diseases. In the present study, we have examined the inhibitory activities of some flavonoids, their biosynthetic precursors (cinnamic acids and coumaric acid), and their derivatives. The proliferative activity of flavonoids on the T-47D estrogen-receptor-positive breast cancer cell line was also evaluated. Among 10 flavonoids, 7,4'-dihydroxyflavone, diosmetin, chrysoeriol, scutellarein, genkwanin and fisetin showed more than 70% inhibition of 17beta-HSD type 1 at 6muM. In a series of 18 derivatives of cinnamic acid, the best inhibitor was 4'-cyanophenyl 3,4-methylenedioxycinnamate, with more than 70% inhibition of 17beta-HSD type 1. None of flavonoids affected the proliferation of T-47D breast cancer cells.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
2.971
1.150
27
43
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
17beta-Hydroxysteroid dehydrogenase type 1; Inhibitors; Flavonoids; Cinnamic acid derivatives
Language
english
Publication Year
2009
Prepublished in Year
2008
HGF-reported in Year
2008
ISSN (print) / ISBN
0303-7207
e-ISSN
1872-8057
Quellenangaben
Volume: 301,
Issue: 1-2,
Pages: 229-234
Publisher
Elsevier
Publishing Place
Shannon
Reviewing status
Peer reviewed
Institute(s)
Institute of Experimental Genetics (IEG)
Research field(s)
Genetics and Epidemiology
PSP Element(s)
FE 70691
Scopus ID
60249103689
Erfassungsdatum
2008-12-31